View Item 

Show simple item record

Is Early Infarct Artery Patency the Goal or Not?
dc.contributor.authorBates, Eric R.en_US
dc.date.accessioned2010-06-01T20:36:14Z
dc.date.available2010-06-01T20:36:14Z
dc.date.issued1992-03en_US
dc.identifier.citationBATES, ERIC R. (1992). "Is Early Infarct Artery Patency the Goal or Not?." Journal of Interventional Cardiology 5(1): 1-4. <http://hdl.handle.net/2027.42/73711>en_US
dc.identifier.issn0896-4327en_US
dc.identifier.issn1540-8183en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73711
dc.format.extent314399 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1992 Futura Publishing Company, Inc.en_US
dc.titleIs Early Infarct Artery Patency the Goal or Not?en_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumFrom the Division of Cardiology, University of Michigan Medical Center, Ann Arbor. Michiganen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73711/1/j.1540-8183.1992.tb00816.x.pdf
dc.identifier.doi10.1111/j.1540-8183.1992.tb00816.xen_US
dc.identifier.sourceJournal of Interventional Cardiologyen_US
dc.identifier.citedreference1. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: Phase I findings. N Engl J Med 1985; 312: 923 – 926.en_US
dc.identifier.citedreferenceSherry S, Marder VJ. Streptokinase and recombinant tissue plasminogen activator (rt-PA) are equally effective in treating acute myocardial infarction. Ann Intern Med 1991; 114: 417 – 423.en_US
dc.identifier.citedreferenceVogel JHK. Thrombolytic therapy of myocardial infarction—it's time for science, not marketing: The perspective of a practicing cardiologist. Clin Cardiol 1991; 14: 548.en_US
dc.identifier.citedreferenceAnderson JL. Overview of patency as an endpoint of thrombolytic therapy. Am J Cardiol 1991; 67: 11E – 16E.en_US
dc.identifier.citedreferenceYusuf S, Sleight P, Held P, et al. Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials. Circulation 1990; 82 ( Suppl. II ): II-117 – II-134.en_US
dc.identifier.citedreferenceKouralenko T, Kereiakes DJ, Gibler WB. Prehospital diagnosis and treatment of acute myocardial infarction: A critical review. Am Heart J 1992; 123: 181 – 190.en_US
dc.identifier.citedreferenceCaliff RM, O'Neill WW, Stack RS, et al. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. Ann Intern Med 1988; 108: 658 – 662.en_US
dc.identifier.citedreferenceBates ER. Is survival in acute myocardial infarction related to thrombolytic efficacy or the open artery hypothesis? A controversy to be investigated with GUSTO. Chest ( In press ).en_US
dc.identifier.citedreferenceCigarroa RG, Lange RA, Hillis LD. Prognosis after acute myocardial infarction in patients with and without residual antegrade coronary blood flow. Am J Cardiol 1989; 64: 155 – 160.en_US
dc.identifier.citedreferenceLange RA, Cigarroa RG, Hillis LD. Influence of residual antegrade coronary blood flow on survival after myocardial infarction in patients with multivessel coronary artery disease. Cor Artery Dis 1990; 1: 56 – 63.en_US
dc.identifier.citedreferenceKwon K, Freedman SB, Wilcox I, et al. The unstable ST segment early after thrombolysis for acute infarction and its usefulness as a marker of recurrent coronary occlusion. Am J Cardiol 1991; 67: 109 – 115.en_US
dc.identifier.citedreferenceSimoons ML. Patency, recurrent ischemia, reocclusion, heparin, and repeated therapy with alteplase: The ECSG heparin trial. Presented at the George Washington University Thombolysis and Interventional Therapy in Acute Myocardial Infarction Symposium, Anaheim, CA, November 10, 1991.en_US
dc.identifier.citedreferenceRoss AM. Relationship of anticoagulation to coronary patency after rt-PA therapy: Further observations from HART. Presented at the George Washington University Thombolysis and Interventional Therapy in Acute Myocardial Infarction Symposium. Anaheim. CA, November 10, 1991.en_US
dc.identifier.citedreferenceO'Connor CM, Meese R, Navetta F, et al. A randomized trial of heparin in conjunction with anistreplase (APSAC) in acute myocardial infarction. (abstract) Circulation 1991; 84 ( Suppl. 11 ): 11 – 571.en_US
dc.identifier.citedreferenceOhman EM, Califf RM. Topol EJ, et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation 1990; 82: 781 – 791.en_US
dc.identifier.citedreferenceHsia J, Hamilton WP. Kleiman N, et al. A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1990; 323: 1433 – 1437.en_US
dc.identifier.citedreferenceBleich SD, Nichols TC, Schumacher RR, et al. Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction. Am J Cardiol 1990; 66: 1412 – 1417.en_US
dc.identifier.citedreferenceMeijer A, Werter CJ, Verhergst FWA. The APRICOT study: Coumarin versus aspirin in the prevention of re-occlusion after successful thrombolysis, a prospective placebo-controlled angiographic study. (abstract) Circulation 1991; 84 ( Suppl. II ): II – 571.en_US
dc.identifier.citedreferenceGripes CL, DeMaria AN. The GUSTO trial: Is it necessary ? J Interven Cardiol 1991; 4: 149 – 153.en_US
dc.identifier.citedreferenceFolts JD, Gallagher K, Rowe GG. Blood flow reductions in stenosed canine coronary arteries: Vasospasm or platelet aggregation ? Circulation 1982; 65: 248 – 255.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1540-8183.1992.tb00816.x.pdf
Size:
307.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.